Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
Recruiting · NCT06278454 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases | Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-06-10 | NCT06278454 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu New Radiomedicine Technology Co. LTD. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chongqing University Cancer Hospital | Chongqing | China | 17 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Second Affiliated Hospital of Soochow University | Suzhou | China | 1 |
| Shanghai Changhai Hospital | Shanghai | China | 4 |
| Shanghai General Hospital | Shanghai | China | 16 |
| Tianjin Medical University General Hospital | Tianjin | China | 28 |